CLDX compared with VRDN: revenue, margins and what each company keeps, and the suppliers and customers both name

CLDXCelldex Therapeutics, Inc.

Mkt capRevenueRevenue

VRDNViridian Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

CLDXCelldex Therapeutics, Inc.

VRDNViridian Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Co-movers

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Co-movers

daily closes · 501dMethod ›

Moved together

CLDXwithVRDN

×0.46co-movement · VRDN on CLDX · 501d

r 0.40scale to r 0.75

Shared co-movers3with CLDXwith VRDN

DNLIDenali Therapeutics Inc.r 0.48r 0.41

NRIXNurix Therapeutics, Inc.r 0.44r 0.36

XNCRXencor Incr 0.48r 0.34

CLDX, solidVRDN, hatched× = co-movement · βr = correlationBar = r to r 0.75Order: weaker of A and BSource: daily closes

CLDXCelldex Therapeutics, Inc.

29.77▲+0.19%· post 29.77

Mkt cap$2.4BRevenue$22,000Q2 FY26Revenue$7MFY24

VRDNViridian Therapeutics, Inc.

29.05▲+15.51%· post 29.62

ClosedNov 4 '26

Mkt cap$3.3BRevenue$26MQ3 FY26Revenue$71MFY25

Compare

ClosedNov 4 '26

CLDXCelldex Therapeutics, Inc.

VRDNViridian Therapeutics, Inc.

29.77▲+0.19%post 29.77

Price

29.05▲+15.51%post 29.62

$2.4B

Mkt cap

$3.3B

Q2 FY26$22,000

Revenue

$26MQ3 FY26

FY24$7M

Revenue

$71MFY25

CLDX29.77▲+0.19%vsVRDN29.05▲+15.51%ClosedNov 4 '26